Skip to main content
. 2017 Dec;187(12):2758–2774. doi: 10.1016/j.ajpath.2017.08.026

Table 3.

Antibodies Used in This Study

Antibody Vendor Catalog no.
CYP2E1 Abcam, Cambridge, MA ab28146
GAPDH EMD Millipore, Billerica, MA MAB374
CYP1A2 Santa Cruz Biotechnology, Dallas, TX sc-53241
AHR Santa Cruz Biotechnology, Dallas, TX sc-5579
MED1 Santa Cruz Biotechnology, Dallas, TX sc-8998
Actin Santa Cruz Biotechnology, Dallas, TX sc-8432
HNF4α Santa Cruz Biotechnology, Dallas, TX sc-8987
HNF6 Santa Cruz Biotechnology, Dallas, TX sc-13050
Ku-86 Santa Cruz Biotechnology, Dallas, TX sc-1484
Ki-67 Cell Signaling Technology, Danvers, MA 12202
Anti-mouse IgG, HRP linked GE Life Sciences, Pittsburgh, PA NA931V
Anti-rabbit IgG, HRP linked GE Life Sciences, Pittsburgh, PA NA934V

AHR, aryl hydrocarbon receptor; CYP1A2, cytochrome P450 family 1 subfamily A member 2; CYP2E1, cytochrome P450 family 2 subfamily E member 1; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HNF, hepatocyte nuclear factor; HRP, horseradish peroxidase; MED1, mediator 1.